Chemours (NYSE:CC – Get Free Report ... Marketbeat Ratings reports. The firm presently has a $19.00 price target on the specialty chemicals company’s stock. Mizuho’s price objective would ...

Fintel reports that on March 27, 2025, Mizuho upgraded their outlook for Chemours (NYSE:CC) from Neutral to Outperform.

Plain Facts compilation, we present data-based insights with easy-to-read charts to help you delve deeper into the stories ...

Global shares are mostly lower as investors mull the uncertainties brought by U.S. President Donald Trump’s latest tariffs.

U.S. stocks are drifting following discouraging updates on inflation and how much U.S. households may be willing to spend.

Atlanticus Holdings Corporation (NASDAQ:ATLC), a specialty finance company focusing on consumer credit, has been navigating a complex landscape of regulatory changes, market dynamics, and economic ...

Victory Capital Management Inc. lowered its position in shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN – Free Report) ...

World markets are mostly lower after a lackluster session on Wall Street as investors remained uneasy over uncertainty over ...

Stocks are falling in afternoon trading but the losses softened enough to give Wall Street a chance to snap a weekly losing ...

According to InvestingPro, the company’s stock has shown significant volatility with a beta of 2.17, reflecting its sensitivity to market conditions ... been a significant source of income for credit ...

Atlanticus Holdings Corporation (NASDAQ:ATLC), a specialty finance company focusing on consumer credit, has been navigating a complex landscape of regulatory changes, market dynamics ... growing ...